Nanobiotix S.A. NBTX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.18% | 30.76% | 62.62% | 25.15% | -54.61% |
| Total Depreciation and Amortization | -2.91% | -1.29% | -3.77% | -0.01% | 5.31% |
| Total Amortization of Deferred Charges | 37.21% | -2.33% | -44.19% | 200.00% | -- |
| Total Other Non-Cash Items | 90.93% | -56.36% | -121.93% | -84.34% | 4.54% |
| Change in Net Operating Assets | -373.81% | -177.83% | -126.48% | -100.34% | -77.43% |
| Cash from Operations | -17.68% | -44.35% | -78.28% | -217.03% | -2,943.85% |
| Capital Expenditure | -115.08% | -24.14% | 32.62% | 20.12% | -3.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.57% | 67.12% | 61.19% | -8.93% | -292.11% |
| Cash from Investing | -72.27% | -7.73% | 35.88% | 17.40% | -18.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.52% | -4.35% | -14.18% | -15.64% | -17.18% |
| Issuance of Common Stock | -- | -- | -- | -97.45% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.26% | -53.88% | -135.51% | 72.47% | 92.91% |
| Cash from Financing | 2,456.12% | 1,707.99% | 889.50% | -13.51% | -111.54% |
| Foreign Exchange rate Adjustments | 216.91% | 137.05% | -524.51% | -930.21% | -4,892.45% |
| Miscellaneous Cash Flow Adjustments | 100.00% | 100.00% | -- | -200.00% | -210.00% |
| Net Change in Cash | 334.38% | 248.14% | 118.24% | -275.86% | -184.38% |